Рак падстраўнікавай залозы (Belarusian Wikipedia)

Harris, RE (2013). Epidemiology of pancreatic cancer. Epidemiology of Chronic Disease. Jones & Bartlett. pp. 181–190. ISBN 978-0-7637-8047-0. Архівавана з арыгінала 24 чэрвеня 2016.
Handbook of Pancreatic Cancer. New York: Springer. 2009. p. 288. ISBN 978-0-387-77497-8. Архівавана з арыгінала 10 September 2017. Праверана 12 June 2016.

cancer.gov (Global: 1,684^th place; Belarusian: 4,262^nd place)

cancer.gov

What is Cancer? Defining Cancer (нявызн.). National Cancer Institute, National Institutes of Health (7 сакавіка 2014). Архівавана з першакрыніцы 25 June 2014. Праверана 5 December 2014.
Pancreatic Cancer Treatment (PDQ®) Patient Version (нявызн.). National Cancer Institute. National Institutes of Health (17 красавіка 2014). Архівавана з першакрыніцы 5 July 2014. Праверана 8 June 2014.
Pancreatic Cancer Treatment (PDQ®) Health Professional Version (нявызн.). National Cancer Institute. National Institutes of Health (21 лютага 2014). Архівавана з першакрыніцы 22 October 2014. Праверана 24 November 2014. «The highest cure rate occurs if the tumor is truly localized to the pancreas; however, this stage of disease accounts for less than 20 % of cases. In cases with localized disease and small cancers (<2 cm) with no lymph node metastases and no extension beyond the capsule of the pancreas, complete surgical resection is still associated with a low actuarial five-year survival rate of 18 % to 24 %.»
National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality Archived copy (нявызн.). Архівавана з першакрыніцы 4 January 2015. Праверана 29 December 2014.
Cancer Drug Information: FDA Approval for Erlotinib Hydrochloride (нявызн.)(недаступная спасылка). National Cancer Institute. National Institutes of Health (3 ліпеня 2013). Архівавана з першакрыніцы 29 лістапада 2014. Праверана 10 студзеня 2021.

seer.cancer.gov

Pancreatic Cancer – Cancer Stat Facts (англ.). SEER. Праверана 4 April 2019.

cancer.org (Global: 3,680^th place; Belarusian: low place)

Can pancreatic cancer be prevented? (нявызн.). American Cancer Society (11 чэрвеня 2014). Архівавана з першакрыніцы 13 November 2014. Праверана 13 November 2014.
Cancer Facts and Figures 2014 (нявызн.). American Cancer Society. Архівавана з першакрыніцы 18 December 2014. Праверана 5 January 2015., p. 19, «Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk.»
Staging of pancreatic cancer (нявызн.)(недаступная спасылка). American Cancer Society (11 чэрвеня 2014). Архівавана з першакрыніцы 10 жніўня 2020. Праверана 29 September 2014.
Diet and activity factors that affect risks for certain cancers: Pancreatic cancer section (нявызн.). American Cancer Society (20 жніўня 2012). Архівавана з першакрыніцы 4 November 2014. Праверана 4 November 2014.
Palliative or Supportive Care (нявызн.). American Cancer Society (16 кастрычніка 2014). Архівавана з першакрыніцы 21 August 2014. Праверана 20 August 2014.
If treatment for pancreatic cancer stops working (нявызн.). American Cancer Society (11 чэрвеня 2014). Архівавана з першакрыніцы 22 October 2014. Праверана 20 August 2014.
Cancer Facts and Figures 2014 (нявызн.). American Cancer Society. Архівавана з першакрыніцы 18 December 2014. Праверана 5 January 2015., Table, p. 18, rates adjusted for normal life expectancy
What's new in pancreatic cancer research and treatment? (нявызн.). American Cancer Society (16 кастрычніка 2019). Праверана 2 May 2019.

cancerresearchuk.org (Global: 8,489^th place; Belarusian: low place)

Pancreatic cancer research (нявызн.). Cancer Research UK. Архівавана з першакрыніцы 18 February 2014. Праверана 17 July 2014.

cancerstaging.org (Global: low place; Belarusian: low place)

Chapter 15; Pancreas (PDF). Manual for Staging of Cancer (2nd ed.). American Joint Committee on Cancer. pp. 95–98. Архівавана (PDF) з арыгінала 29 Лістапад 2014. See p. 95 for citation regarding «… lesser degree of involvement of bones and brain and other anatomical sites.»

doi.org (Global: 2^nd place; Belarusian: 22^nd place)

Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel (11 September 2014). Pancreatic Adenocarcinoma. New England Journal of Medicine. 371 (11): 1039–1049. doi:10.1056/NEJMra1404198. PMID 25207767.
Bond-Smith, G.; Banga, N.; Hammond, T. M.; Imber, C. J. (16 May 2012). Pancreatic adenocarcinoma. BMJ. 344 (may16 1): e2476. doi:10.1136/bmj.e2476. PMID 22592847.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). Recent progress in pancreatic cancer. CA: A Cancer Journal for Clinicians. 63 (5): 318–348. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (Жнівень 2011). Pancreatic cancer (PDF). Lancet. 378 (9791): 607–620. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Архівавана з арыгінала (PDF) 12 студзеня 2015. Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.
Bardou M, Le Ray I (December 2013). Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies. Best Practice & Research. Clinical Gastroenterology. 27 (6): 881–892. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
Sperti C, Moletta L, Patanè G (15 October 2014). Metastatic tumors to the pancreas: The role of surgery. World Journal of Gastrointestinal Oncology. 6 (10): 381–392. doi:10.4251/wjgo.v6.i10.381. PMC 4197429. PMID 25320654.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281. {{cite journal}}: |first1= мае агульную назву (даведка)Папярэджанні CS1: лічбавыя назвы: authors list (спасылка)
Oberg, K.; Knigge, U.; Kwekkeboom, D.; Perren, A.; ESMO Guidelines Working, Group. (20 September 2012). Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23 (suppl 7): vii124–vii130. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Farrell JJ, Fernández-del Castillo C (June 2013). Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 144 (6): 1303–1315. doi:10.1053/j.gastro.2013.01.073. PMID 23622140.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system WHO classification of tumours of the digestive system – NLM Catalog – NCBI (нявызн.). Архівавана з першакрыніцы 9 September 2017. Праверана 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called «pancreatic endocrine tumors». See: Klimstra, David S.; Modlin, Irvin R.; Coppola, Domenico; Lloyd, Ricardo V.; Suster, Saul (August 2010). The Pathologic Classification of Neuroendocrine Tumors. Pancreas. 39 (6): 707–712. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470.
Burns WR, Edil BH (March 2012). Neuroendocrine pancreatic tumors: guidelines for management and update. Current Treatment Options in Oncology. 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID 22198808.
Pannala R, Basu A, Petersen GM, Chari ST (January 2009). New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. The Lancet. Oncology. 10 (1): 88–95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C (July 2012). Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Annals of Oncology. 23 (7): 1880–1888. doi:10.1093/annonc/mdr541. PMC 3387822. PMID 22104574.
Peters, ML; Tseng, JF; Miksad, RA (31 March 2016). Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. Clinical Therapeutics. 38 (7): 1622–1635. doi:10.1016/j.clinthera.2016.03.006. PMID 27041411.
Reznik R, Hendifar AE, Tuli R (2014). Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma. Front Physiol. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Larsson SC, Wolk A (студзеня 2012). Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 106 (3): 603–607. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P (2011). Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics. 12 (1): 15–24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Rooney, Sarah L.; Shi, Jiaqi (October 2016). Intraductal Tubulopapillary Neoplasm of the Pancreas: An Update From a Pathologist's Perspective. Archives of Pathology & Laboratory Medicine. 140 (10): 1068–1073. doi:10.5858/arpa.2016-0207-RA. PMID 27684978.
Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjöstedt, Evelina; Fagerberg, Linn; Bidkhori, Gholamreza; Benfeitas, Rui; Arif, Muhammad; Liu, Zhengtao (18 August 2017). A pathology atlas of the human cancer transcriptome. Science(англ.). 357 (6352): eaan2507. doi:10.1126/science.aan2507. ISSN 0036-8075. PMID 28818916.
Lewis MA, Yao JC (February 2014). Molecular pathology and genetics of gastrointestinal neuroendocrine tumours. Current Opinion in Endocrinology, Diabetes and Obesity. 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID 24310147.
Thakker, Rajesh V.; Newey, Paul J.; Walls, Gerard V.; Bilezikian, John; Dralle, Henning; Ebeling, Peter R.; Melmed, Shlomo; Sakurai, Akihiro; Tonelli, Francesco; Brandi, Maria Luisa; Endocrine, Society. (1 September 2012). Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). The Journal of Clinical Endocrinology & Metabolism. 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID 22723327.
Fitzgerald, J. Edward F.; White, Matthew J.; Lobo, Dileep N. (4 February 2009). Courvoisier's Gallbladder: Law or Sign?. World Journal of Surgery. 33 (4): 886–891. doi:10.1007/s00268-008-9908-y. PMID 19190960.
Piraka, Cyrus; Scheiman, James M. (September 2011). New diagnostic imaging modalities for pancreatic disease. Current Opinion in Gastroenterology. 27 (5): 475–480. doi:10.1097/MOG.0b013e328349e30c. PMID 21743318.
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (October 2012). Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23 Suppl 7: vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.
Skafida, Evangelia; Grammatoglou, Xanthippi; Glava, Chryssoula; Zissis, Dimitrios; Paschalidis, Nikolaos; Katsamagkou, Eleftheria; Firfiris, Nikolaos; Vasilakaki, Thivi (2010). Adenosquamous carcinoma of the pancreas: a case report. Cases Journal. 3 (1). doi:10.1186/1757-1626-3-41. ISSN 1757-1626.
Adsay, Volkan; Mino-Kenudson, Mari; Furukawa, Toru; Basturk, Olca; Zamboni, Giuseppe; Marchegiani, Giovanni; Bassi, Claudio; Salvia, Roberto; Malleo, Giuseppe; Paiella, Salvatore; Wolfgang, Christopher L.; Matthaei, Hanno; Offerhaus, G. Johan; Adham, Mustapha; Bruno, Marco J.; Reid, Michelle D.; Krasinskas, Alyssa; Klöppel, Günter; Ohike, Nobuyuki; Tajiri, Takuma; Jang, Kee-Taek; Roa, Juan Carlos; Allen, Peter; Castillo, Carlos Fernández-del; Jang, Jin-Young; Klimstra, David S.; Hruban, Ralph H. (2016). Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract. Annals of Surgery. 263 (1): 162–177. doi:10.1097/SLA.0000000000001173. ISSN 0003-4932. PMC 4568174. PMID 25775066.
Cascinu, S.; Falconi, M.; Valentini, V.; Jelic, S.; ESMO Guidelines Working, Group. (16 June 2010). Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21 (Supplement 5): v55–v58. doi:10.1093/annonc/mdq165. PMID 20555103.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (August 2019). Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 322 (5): 438–444. doi:10.1001/jama.2019.10232. PMID 31386141.
He XY, Yuan YZ (August 2014). Advances in pancreatic cancer research: moving towards early detection. World Journal of Gastroenterology. 20 (32): 11241–8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Okano K, Suzuki Y (August 2014). Strategies for early detection of resectable pancreatic cancer. World Journal of Gastroenterology. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. (January 2020). Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 69 (1): 7–17. doi:10.1136/gutjnl-2019-319352. PMC 7295005. PMID 31672839.
Gurusamy KS, Kumar S, Davidson BR, Fusai G (February 2014). Resection versus other treatments for locally advanced pancreatic cancer. The Cochrane Database of Systematic Reviews. 2 (2): CD010244. doi:10.1002/14651858.CD010244.pub2. PMID 24578248.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, et al. (October 2014). Improving outcomes in pancreatic cancer: key points in perioperative management. World Journal of Gastroenterology. 20 (39): 14237–45. doi:10.3748/wjg.v20.i39.14237. PMC 4202352. PMID 25339810.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Lopez NE, Prendergast C, Lowy AM (August 2014). Borderline resectable pancreatic cancer: definitions and management. World Journal of Gastroenterology. 20 (31): 10740–51. doi:10.3748/wjg.v20.i31.10740. PMC 4138454. PMID 25152577.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M (July 2014). Neoadjuvant strategies for pancreatic cancer. World Journal of Gastroenterology. 20 (28): 9374–83. doi:10.3748/wjg.v20.i28.9374 (неактыўны 2020-08-23). PMC 4110569. PMID 25071332.{{cite journal}}: Папярэджанні CS1: неактыўны DOI з жнівень 2020 (спасылка) Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (April 2010). Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLOS Medicine. 7 (4): e1000267. doi:10.1371/journal.pmed.1000267. PMC 2857873. PMID 20422030.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Christians KK, Evans DB (June 2015). Additional support for neoadjuvant therapy in the management of pancreatic cancer. Annals of Surgical Oncology. 22 (6): 1755–8. doi:10.1245/s10434-014-4307-0. PMID 25519932.
Tsvetkova EV, Asmis TR (August 2014). Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?. Current Oncology. 21 (4): e650-7. doi:10.3747/co.21.2006. PMC 4117630. PMID 25089113.
Zhan HX, Xu JW, Wu D, Zhang TP, Hu SY (February 2015). Pancreatic cancer stem cells: new insight into a stubborn disease. Cancer Letters. 357 (2): 429–37. doi:10.1016/j.canlet.2014.12.004. PMID 25499079.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, et al. (August 2014). Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World Journal of Gastroenterology. 20 (31): 10790–801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR (July 2016). Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. The Cochrane Database of Systematic Reviews. 7: CD009323. doi:10.1002/14651858.CD009323.pub3. PMC 6458011. PMID 27383694.
Heinemann V, Haas M, Boeck S (October 2013). Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Annals of Oncology. 24 (10): 2484–92. doi:10.1093/annonc/mdt239. PMID 23852311.
Borazanci E, Von Hoff DD (September 2014). Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer. Expert Review of Gastroenterology & Hepatology. 8 (7): 739–47. doi:10.1586/17474124.2014.925799. PMID 24882381. S2CID 31633898.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, et al. (2012). ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 95 (2): 120–34. doi:10.1159/000335587. PMID 22261872. S2CID 6985904.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. (2012). ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, et al. (2012). ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 95 (2): 157–76. doi:10.1159/000335597. PMID 22262022. S2CID 2097604.
Rossi RE, Massironi S, Conte D, Peracchi M (January 2014). Therapy for metastatic pancreatic neuroendocrine tumors. Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01. PMC 4200651. PMID 25332984.
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (May 2012). Radionuclide therapy in neuroendocrine tumours: a systematic review. Clinical Oncology. 24 (4): 294–308. doi:10.1016/j.clon.2011.12.003. PMID 22221516.
Vinik AI (November 2014). Advances in diagnosis and treatment of pancreatic neuroendocrine tumors. Endocrine Practice. 20 (11): 1222–30. doi:10.4158/EP14373.RA. PMID 25297671.
Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP (March 2010). Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Seminars in Nuclear Medicine. 40 (2): 78–88. doi:10.1053/j.semnuclmed.2009.10.004. PMID 20113677.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (August 2014). Peptide receptor radionuclide therapy for advanced neuroendocrine tumors. Thoracic Surgery Clinics. 24 (3): 333–49. doi:10.1016/j.thorsurg.2014.04.005. hdl:11392/2378236. PMID 25065935.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (June 2015). Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors. Cancer Chemotherapy and Pharmacology. 75 (6): 1099–114. doi:10.1007/s00280-014-2642-2. PMID 25480314. S2CID 39434924.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, et al. (August 2015). Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group. Annals of Surgical Oncology. 22 (8): 2685–99. doi:10.1245/s10434-014-4145-0. PMID 25366583. S2CID 8129133.
Buanes TA (August 2014). Pancreatic cancer-improved care achievable. World Journal of Gastroenterology. 20 (30): 10405–18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (March 2011). Arcidiacono PG (рэд.). Celiac plexus block for pancreatic cancer pain in adults. The Cochrane Database of Systematic Reviews (3): CD007519. doi:10.1002/14651858.CD007519.pub2. PMC 6464722. PMID 21412903.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). Cancer statistics, 2007. Ca. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.
Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (November 1983). History of the pancreas. American Journal of Surgery. 146 (5): 539–50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.
Are C, Dhir M, Ravipati L (June 2011). History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB. 13 (6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (July 2006). One thousand consecutive pancreaticoduodenectomies. Annals of Surgery. 244 (1): 10–5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. (September 2012). Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (September 2015). Pancreatic cancer genomics: where can the science take us?. Clinical Genetics. 88 (3): 213–9. doi:10.1111/cge.12536. PMID 25388820. S2CID 26414866.
Zhang C, Yang G, Ling Y, Chen G, Zhou T (December 2014). The early diagnosis of pancreatic cancer and diabetes: what's the relationship?. Journal of Gastrointestinal Oncology. 5 (6): 481–8. doi:10.3978/j.issn.2078-6891.2014.055. PMC 4226830. PMID 25436129.
Bruenderman EH, Martin RC (March 2015). High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. The Journal of Surgical Research. 194 (1): 212–9. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Subar D, Gobardhan PD, Gayet B (February 2014). Laparoscopic pancreatic surgery: An overview of the literature and experiences of a single center. Best Practice & Research. Clinical Gastroenterology. 28 (1): 123–32. doi:10.1016/j.bpg.2013.11.011. PMID 24485260.
Weiss MJ, Wolfgang CL (2013). Irreversible electroporation: a novel pancreatic cancer therapy. Current Problems in Cancer. 37 (5): 262–5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180.
Moir J, White SA, French JJ, Littler P, Manas DM (December 2014). Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. European Journal of Surgical Oncology. 40 (12): 1598–604. doi:10.1016/j.ejso.2014.08.480. PMID 25307210.
Kleger A, Perkhofer L, Seufferlein T (July 2014). Smarter drugs emerging in pancreatic cancer therapy. Annals of Oncology. 25 (7): 1260–1270. doi:10.1093/annonc/mdu013. PMID 24631947.
Tang SC, Chen YC (Жнівень 2014). Novel therapeutic targets for pancreatic cancer. World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Rossi ML, Rehman AA, Gondi CS (August 2014). Therapeutic options for the management of pancreatic cancer. World Journal of Gastroenterology. 20 (32): 11142–59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Ady JW, Heffner J, Klein E, Fong Y (2014). Oncolytic viral therapy for pancreatic cancer: current research and future directions. Oncolytic Virotherapy. 3: 35–46. doi:10.2147/OV.S53858. PMC 4918362. PMID 27512661.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Ren B, Cui M, Yang G, Wang H, Feng M, You L, Zhao Y (July 2018). Tumor microenvironment participates in metastasis of pancreatic cancer. Molecular Cancer. 17 (1): 108. doi:10.1186/s12943-018-0858-1. PMC 6065152. PMID 30060755.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)

europac-org.eu (Global: low place; Belarusian: low place)

About EUROPAC (нявызн.)(недаступная спасылка). European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC). University of Liverpool. Архівавана з першакрыніцы 26 July 2014. Праверана 17 July 2014.

handle.net (Global: 102^nd place; Belarusian: 1,042^nd place)

hdl.handle.net

Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (August 2014). Peptide receptor radionuclide therapy for advanced neuroendocrine tumors. Thoracic Surgery Clinics. 24 (3): 333–49. doi:10.1016/j.thorsurg.2014.04.005. hdl:11392/2378236. PMID 25065935.

harvard.edu (Global: 18^th place; Belarusian: 75^th place)

ui.adsabs.harvard.edu

Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.

iarc.fr (Global: 4,025^th place; Belarusian: 7,594^th place)

publications.iarc.fr

Stewart, B.W. and Wild, C.P. (Eds.). World Cancer Report 2014 [World Health Organization]. — Lyon: International Agency for Research on Cancer, 2014. — Раздзел 5, 7. — ISBN 978-92-832-0443-5.

jhu.edu (Global: 699^th place; Belarusian: 463^rd place)

pathology.jhu.edu

Types of Pancreas Tumors (нявызн.). The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine (16 кастрычніка 2012). Архівавана з першакрыніцы 8 October 2014. Праверана 18 November 2014.
Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas (нявызн.). The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine (16 кастрычніка 2012). Архівавана з першакрыніцы 5 January 2015. Праверана 5 January 2015.

lwwoncology.com (Global: low place; Belarusian: low place)

Zyromski, Nicholas J.; Nakeeb, Attila; Lillemoe, Keith D. (2010). Silberman, Howard; Silberman, Allan W. (рэд-ры). Principles and practice of surgical oncology : multidisciplinary approach to difficult problems (online ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. Chapter 35. ISBN 978-0-7817-6546-6. Архівавана з арыгінала 6 February 2015. Праверана 3 November 2014.{{cite book}}: Папярэджанні CS1: бот: невядомы статус арыгінальнага URL (спасылка) Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 6 лютага 2015. Праверана 7 жніўня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 6 лютага 2015. Праверана 7 жніўня 2020.

nccn.org (Global: low place; Belarusian: low place)

Neuroendocrine tumors, NCCN Guidelines Version 1.2015 (нявызн.)(недаступная спасылка). National Comprehensive Cancer Network, Inc. NCCN) (11 лістапада 2014). Архівавана з першакрыніцы 24 красавіка 2021. Праверана 25 December 2014.
Pancreatic adenocarcinoma. NCCN Guidelines Version 1.2015 (нявызн.)(недаступная спасылка). NCCN Guidelines. National Comprehensive Cancer Network, Inc. (4 снежня 2014). Архівавана з першакрыніцы 8 лютага 2007. Праверана 26 December 2014.

nhs.uk (Global: 1,989^th place; Belarusian: 2,156^th place)

Causes of pancreatic cancer (нявызн.). NHS Choices. National Health Service, England (7 кастрычніка 2014). Архівавана з першакрыніцы 6 November 2014. Праверана 5 December 2014.

nih.gov (Global: 4^th place; Belarusian: 66^th place)

pubmed.ncbi.nlm.nih.gov

Unless otherwise specified in boxes, reference is: Pishvaian MJ, Brody JR (2017). Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer. Oncology (Williston Park). 31 (3): 159–66, 168. PMID 28299752.
Ryan, David P.; Hong, Theodore S.; Bardeesy, Nabeel (11 September 2014). Pancreatic Adenocarcinoma. New England Journal of Medicine. 371 (11): 1039–1049. doi:10.1056/NEJMra1404198. PMID 25207767.
Bond-Smith, G.; Banga, N.; Hammond, T. M.; Imber, C. J. (16 May 2012). Pancreatic adenocarcinoma. BMJ. 344 (may16 1): e2476. doi:10.1136/bmj.e2476. PMID 22592847.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). Recent progress in pancreatic cancer. CA: A Cancer Journal for Clinicians. 63 (5): 318–348. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (Жнівень 2011). Pancreatic cancer (PDF). Lancet. 378 (9791): 607–620. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Архівавана з арыгінала (PDF) 12 студзеня 2015. Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.
Bardou M, Le Ray I (December 2013). Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies. Best Practice & Research. Clinical Gastroenterology. 27 (6): 881–892. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
Sperti C, Moletta L, Patanè G (15 October 2014). Metastatic tumors to the pancreas: The role of surgery. World Journal of Gastrointestinal Oncology. 6 (10): 381–392. doi:10.4251/wjgo.v6.i10.381. PMC 4197429. PMID 25320654.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281. {{cite journal}}: |first1= мае агульную назву (даведка)Папярэджанні CS1: лічбавыя назвы: authors list (спасылка)
Oberg, K.; Knigge, U.; Kwekkeboom, D.; Perren, A.; ESMO Guidelines Working, Group. (20 September 2012). Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23 (suppl 7): vii124–vii130. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Farrell JJ, Fernández-del Castillo C (June 2013). Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 144 (6): 1303–1315. doi:10.1053/j.gastro.2013.01.073. PMID 23622140.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system WHO classification of tumours of the digestive system – NLM Catalog – NCBI (нявызн.). Архівавана з першакрыніцы 9 September 2017. Праверана 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called «pancreatic endocrine tumors». See: Klimstra, David S.; Modlin, Irvin R.; Coppola, Domenico; Lloyd, Ricardo V.; Suster, Saul (August 2010). The Pathologic Classification of Neuroendocrine Tumors. Pancreas. 39 (6): 707–712. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470.
Burns WR, Edil BH (March 2012). Neuroendocrine pancreatic tumors: guidelines for management and update. Current Treatment Options in Oncology. 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID 22198808.
Pannala R, Basu A, Petersen GM, Chari ST (January 2009). New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. The Lancet. Oncology. 10 (1): 88–95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C (July 2012). Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Annals of Oncology. 23 (7): 1880–1888. doi:10.1093/annonc/mdr541. PMC 3387822. PMID 22104574.
Peters, ML; Tseng, JF; Miksad, RA (31 March 2016). Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. Clinical Therapeutics. 38 (7): 1622–1635. doi:10.1016/j.clinthera.2016.03.006. PMID 27041411.
Reznik R, Hendifar AE, Tuli R (2014). Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma. Front Physiol. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Larsson SC, Wolk A (студзеня 2012). Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 106 (3): 603–607. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Pericleous M, Rossi RE, Mandair D, Whyand T, Caplin ME (January 2014). Nutrition and pancreatic cancer. Anticancer Research. 34 (1): 9–21. PMID 24403441.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P (2011). Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics. 12 (1): 15–24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Rooney, Sarah L.; Shi, Jiaqi (October 2016). Intraductal Tubulopapillary Neoplasm of the Pancreas: An Update From a Pathologist's Perspective. Archives of Pathology & Laboratory Medicine. 140 (10): 1068–1073. doi:10.5858/arpa.2016-0207-RA. PMID 27684978.
Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjöstedt, Evelina; Fagerberg, Linn; Bidkhori, Gholamreza; Benfeitas, Rui; Arif, Muhammad; Liu, Zhengtao (18 August 2017). A pathology atlas of the human cancer transcriptome. Science(англ.). 357 (6352): eaan2507. doi:10.1126/science.aan2507. ISSN 0036-8075. PMID 28818916.
Lewis MA, Yao JC (February 2014). Molecular pathology and genetics of gastrointestinal neuroendocrine tumours. Current Opinion in Endocrinology, Diabetes and Obesity. 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID 24310147.
Thakker, Rajesh V.; Newey, Paul J.; Walls, Gerard V.; Bilezikian, John; Dralle, Henning; Ebeling, Peter R.; Melmed, Shlomo; Sakurai, Akihiro; Tonelli, Francesco; Brandi, Maria Luisa; Endocrine, Society. (1 September 2012). Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). The Journal of Clinical Endocrinology & Metabolism. 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID 22723327.
De La Cruz MS, Young AP, Ruffin MT (April 2014). Diagnosis and management of pancreatic cancer. Am Fam Physician. 89 (8): 626–632. PMID 24784121.
Fitzgerald, J. Edward F.; White, Matthew J.; Lobo, Dileep N. (4 February 2009). Courvoisier's Gallbladder: Law or Sign?. World Journal of Surgery. 33 (4): 886–891. doi:10.1007/s00268-008-9908-y. PMID 19190960.
Piraka, Cyrus; Scheiman, James M. (September 2011). New diagnostic imaging modalities for pancreatic disease. Current Opinion in Gastroenterology. 27 (5): 475–480. doi:10.1097/MOG.0b013e328349e30c. PMID 21743318.
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (October 2012). Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23 Suppl 7: vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.
Adsay, Volkan; Mino-Kenudson, Mari; Furukawa, Toru; Basturk, Olca; Zamboni, Giuseppe; Marchegiani, Giovanni; Bassi, Claudio; Salvia, Roberto; Malleo, Giuseppe; Paiella, Salvatore; Wolfgang, Christopher L.; Matthaei, Hanno; Offerhaus, G. Johan; Adham, Mustapha; Bruno, Marco J.; Reid, Michelle D.; Krasinskas, Alyssa; Klöppel, Günter; Ohike, Nobuyuki; Tajiri, Takuma; Jang, Kee-Taek; Roa, Juan Carlos; Allen, Peter; Castillo, Carlos Fernández-del; Jang, Jin-Young; Klimstra, David S.; Hruban, Ralph H. (2016). Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract. Annals of Surgery. 263 (1): 162–177. doi:10.1097/SLA.0000000000001173. ISSN 0003-4932. PMC 4568174. PMID 25775066.
Cascinu, S.; Falconi, M.; Valentini, V.; Jelic, S.; ESMO Guidelines Working, Group. (16 June 2010). Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21 (Supplement 5): v55–v58. doi:10.1093/annonc/mdq165. PMID 20555103.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (August 2019). Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 322 (5): 438–444. doi:10.1001/jama.2019.10232. PMID 31386141.
He XY, Yuan YZ (August 2014). Advances in pancreatic cancer research: moving towards early detection. World Journal of Gastroenterology. 20 (32): 11241–8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Okano K, Suzuki Y (August 2014). Strategies for early detection of resectable pancreatic cancer. World Journal of Gastroenterology. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. (January 2020). Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 69 (1): 7–17. doi:10.1136/gutjnl-2019-319352. PMC 7295005. PMID 31672839.
Gurusamy KS, Kumar S, Davidson BR, Fusai G (February 2014). Resection versus other treatments for locally advanced pancreatic cancer. The Cochrane Database of Systematic Reviews. 2 (2): CD010244. doi:10.1002/14651858.CD010244.pub2. PMID 24578248.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, et al. (October 2014). Improving outcomes in pancreatic cancer: key points in perioperative management. World Journal of Gastroenterology. 20 (39): 14237–45. doi:10.3748/wjg.v20.i39.14237. PMC 4202352. PMID 25339810.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Lopez NE, Prendergast C, Lowy AM (August 2014). Borderline resectable pancreatic cancer: definitions and management. World Journal of Gastroenterology. 20 (31): 10740–51. doi:10.3748/wjg.v20.i31.10740. PMC 4138454. PMID 25152577.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M (July 2014). Neoadjuvant strategies for pancreatic cancer. World Journal of Gastroenterology. 20 (28): 9374–83. doi:10.3748/wjg.v20.i28.9374 (неактыўны 2020-08-23). PMC 4110569. PMID 25071332.{{cite journal}}: Папярэджанні CS1: неактыўны DOI з жнівень 2020 (спасылка) Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (April 2010). Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLOS Medicine. 7 (4): e1000267. doi:10.1371/journal.pmed.1000267. PMC 2857873. PMID 20422030.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Christians KK, Evans DB (June 2015). Additional support for neoadjuvant therapy in the management of pancreatic cancer. Annals of Surgical Oncology. 22 (6): 1755–8. doi:10.1245/s10434-014-4307-0. PMID 25519932.
Tsvetkova EV, Asmis TR (August 2014). Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?. Current Oncology. 21 (4): e650-7. doi:10.3747/co.21.2006. PMC 4117630. PMID 25089113.
Zhan HX, Xu JW, Wu D, Zhang TP, Hu SY (February 2015). Pancreatic cancer stem cells: new insight into a stubborn disease. Cancer Letters. 357 (2): 429–37. doi:10.1016/j.canlet.2014.12.004. PMID 25499079.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, et al. (August 2014). Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World Journal of Gastroenterology. 20 (31): 10790–801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR (July 2016). Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. The Cochrane Database of Systematic Reviews. 7: CD009323. doi:10.1002/14651858.CD009323.pub3. PMC 6458011. PMID 27383694.
Heinemann V, Haas M, Boeck S (October 2013). Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Annals of Oncology. 24 (10): 2484–92. doi:10.1093/annonc/mdt239. PMID 23852311.
Thota R, Pauff JM, Berlin JD (January 2014). Treatment of metastatic pancreatic adenocarcinoma: a review. Oncology. 28 (1): 70–74. PMID 24683721.
Borazanci E, Von Hoff DD (September 2014). Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer. Expert Review of Gastroenterology & Hepatology. 8 (7): 739–47. doi:10.1586/17474124.2014.925799. PMID 24882381. S2CID 31633898.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, et al. (2012). ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 95 (2): 120–34. doi:10.1159/000335587. PMID 22261872. S2CID 6985904.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. (2012). ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, et al. (2012). ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 95 (2): 157–76. doi:10.1159/000335597. PMID 22262022. S2CID 2097604.
Rossi RE, Massironi S, Conte D, Peracchi M (January 2014). Therapy for metastatic pancreatic neuroendocrine tumors. Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01. PMC 4200651. PMID 25332984.
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (May 2012). Radionuclide therapy in neuroendocrine tumours: a systematic review. Clinical Oncology. 24 (4): 294–308. doi:10.1016/j.clon.2011.12.003. PMID 22221516.
Vinik AI (November 2014). Advances in diagnosis and treatment of pancreatic neuroendocrine tumors. Endocrine Practice. 20 (11): 1222–30. doi:10.4158/EP14373.RA. PMID 25297671.
Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP (March 2010). Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Seminars in Nuclear Medicine. 40 (2): 78–88. doi:10.1053/j.semnuclmed.2009.10.004. PMID 20113677.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (August 2014). Peptide receptor radionuclide therapy for advanced neuroendocrine tumors. Thoracic Surgery Clinics. 24 (3): 333–49. doi:10.1016/j.thorsurg.2014.04.005. hdl:11392/2378236. PMID 25065935.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (June 2015). Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors. Cancer Chemotherapy and Pharmacology. 75 (6): 1099–114. doi:10.1007/s00280-014-2642-2. PMID 25480314. S2CID 39434924.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, et al. (August 2015). Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group. Annals of Surgical Oncology. 22 (8): 2685–99. doi:10.1245/s10434-014-4145-0. PMID 25366583. S2CID 8129133.
Buanes TA (August 2014). Pancreatic cancer-improved care achievable. World Journal of Gastroenterology. 20 (30): 10405–18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (March 2011). Arcidiacono PG (рэд.). Celiac plexus block for pancreatic cancer pain in adults. The Cochrane Database of Systematic Reviews (3): CD007519. doi:10.1002/14651858.CD007519.pub2. PMC 6464722. PMID 21412903.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). Cancer statistics, 2007. Ca. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.
Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (November 1983). History of the pancreas. American Journal of Surgery. 146 (5): 539–50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.
Are C, Dhir M, Ravipati L (June 2011). History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB. 13 (6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (July 2006). One thousand consecutive pancreaticoduodenectomies. Annals of Surgery. 244 (1): 10–5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. (September 2012). Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (September 2015). Pancreatic cancer genomics: where can the science take us?. Clinical Genetics. 88 (3): 213–9. doi:10.1111/cge.12536. PMID 25388820. S2CID 26414866.
Zhang C, Yang G, Ling Y, Chen G, Zhou T (December 2014). The early diagnosis of pancreatic cancer and diabetes: what's the relationship?. Journal of Gastrointestinal Oncology. 5 (6): 481–8. doi:10.3978/j.issn.2078-6891.2014.055. PMC 4226830. PMID 25436129.
Bruenderman EH, Martin RC (March 2015). High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. The Journal of Surgical Research. 194 (1): 212–9. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Subar D, Gobardhan PD, Gayet B (February 2014). Laparoscopic pancreatic surgery: An overview of the literature and experiences of a single center. Best Practice & Research. Clinical Gastroenterology. 28 (1): 123–32. doi:10.1016/j.bpg.2013.11.011. PMID 24485260.
Weiss MJ, Wolfgang CL (2013). Irreversible electroporation: a novel pancreatic cancer therapy. Current Problems in Cancer. 37 (5): 262–5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180.
Moir J, White SA, French JJ, Littler P, Manas DM (December 2014). Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. European Journal of Surgical Oncology. 40 (12): 1598–604. doi:10.1016/j.ejso.2014.08.480. PMID 25307210.
Kleger A, Perkhofer L, Seufferlein T (July 2014). Smarter drugs emerging in pancreatic cancer therapy. Annals of Oncology. 25 (7): 1260–1270. doi:10.1093/annonc/mdu013. PMID 24631947.
Tang SC, Chen YC (Жнівень 2014). Novel therapeutic targets for pancreatic cancer. World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Rossi ML, Rehman AA, Gondi CS (August 2014). Therapeutic options for the management of pancreatic cancer. World Journal of Gastroenterology. 20 (32): 11142–59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Ady JW, Heffner J, Klein E, Fong Y (2014). Oncolytic viral therapy for pancreatic cancer: current research and future directions. Oncolytic Virotherapy. 3: 35–46. doi:10.2147/OV.S53858. PMC 4918362. PMID 27512661.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Ren B, Cui M, Yang G, Wang H, Feng M, You L, Zhao Y (July 2018). Tumor microenvironment participates in metastasis of pancreatic cancer. Molecular Cancer. 17 (1): 108. doi:10.1186/s12943-018-0858-1. PMC 6065152. PMID 30060755.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)

ncbi.nlm.nih.gov

Unless otherwise specified in boxes, reference is: Pishvaian MJ, Brody JR (2017). Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer. Oncology (Williston Park). 31 (3): 159–66, 168. PMID 28299752.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). Recent progress in pancreatic cancer. CA: A Cancer Journal for Clinicians. 63 (5): 318–348. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (Жнівень 2011). Pancreatic cancer (PDF). Lancet. 378 (9791): 607–620. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Архівавана з арыгінала (PDF) 12 студзеня 2015. Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.
Sperti C, Moletta L, Patanè G (15 October 2014). Metastatic tumors to the pancreas: The role of surgery. World Journal of Gastrointestinal Oncology. 6 (10): 381–392. doi:10.4251/wjgo.v6.i10.381. PMC 4197429. PMID 25320654.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281. {{cite journal}}: |first1= мае агульную назву (даведка)Папярэджанні CS1: лічбавыя назвы: authors list (спасылка)
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system WHO classification of tumours of the digestive system – NLM Catalog – NCBI (нявызн.). Архівавана з першакрыніцы 9 September 2017. Праверана 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called «pancreatic endocrine tumors». See: Klimstra, David S.; Modlin, Irvin R.; Coppola, Domenico; Lloyd, Ricardo V.; Suster, Saul (August 2010). The Pathologic Classification of Neuroendocrine Tumors. Pancreas. 39 (6): 707–712. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470.
Pannala R, Basu A, Petersen GM, Chari ST (January 2009). New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. The Lancet. Oncology. 10 (1): 88–95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Bamlet WR, Holly EA, Bertuccio P, Gao YT, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Boffetta P, La Vecchia C (July 2012). Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Annals of Oncology. 23 (7): 1880–1888. doi:10.1093/annonc/mdr541. PMC 3387822. PMID 22104574.
Reznik R, Hendifar AE, Tuli R (2014). Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma. Front Physiol. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Larsson SC, Wolk A (студзеня 2012). Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 106 (3): 603–607. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, Torrisani J, Cordelier P (2011). Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics. 12 (1): 15–24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Adsay, Volkan; Mino-Kenudson, Mari; Furukawa, Toru; Basturk, Olca; Zamboni, Giuseppe; Marchegiani, Giovanni; Bassi, Claudio; Salvia, Roberto; Malleo, Giuseppe; Paiella, Salvatore; Wolfgang, Christopher L.; Matthaei, Hanno; Offerhaus, G. Johan; Adham, Mustapha; Bruno, Marco J.; Reid, Michelle D.; Krasinskas, Alyssa; Klöppel, Günter; Ohike, Nobuyuki; Tajiri, Takuma; Jang, Kee-Taek; Roa, Juan Carlos; Allen, Peter; Castillo, Carlos Fernández-del; Jang, Jin-Young; Klimstra, David S.; Hruban, Ralph H. (2016). Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract. Annals of Surgery. 263 (1): 162–177. doi:10.1097/SLA.0000000000001173. ISSN 0003-4932. PMC 4568174. PMID 25775066.
He XY, Yuan YZ (August 2014). Advances in pancreatic cancer research: moving towards early detection. World Journal of Gastroenterology. 20 (32): 11241–8. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Okano K, Suzuki Y (August 2014). Strategies for early detection of resectable pancreatic cancer. World Journal of Gastroenterology. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. (January 2020). Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 69 (1): 7–17. doi:10.1136/gutjnl-2019-319352. PMC 7295005. PMID 31672839.
Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, et al. (October 2014). Improving outcomes in pancreatic cancer: key points in perioperative management. World Journal of Gastroenterology. 20 (39): 14237–45. doi:10.3748/wjg.v20.i39.14237. PMC 4202352. PMID 25339810.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Lopez NE, Prendergast C, Lowy AM (August 2014). Borderline resectable pancreatic cancer: definitions and management. World Journal of Gastroenterology. 20 (31): 10740–51. doi:10.3748/wjg.v20.i31.10740. PMC 4138454. PMID 25152577.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M (July 2014). Neoadjuvant strategies for pancreatic cancer. World Journal of Gastroenterology. 20 (28): 9374–83. doi:10.3748/wjg.v20.i28.9374 (неактыўны 2020-08-23). PMC 4110569. PMID 25071332.{{cite journal}}: Папярэджанні CS1: неактыўны DOI з жнівень 2020 (спасылка) Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Gillen S, Schuster T, Meyer Zum Büschenfelde C, Friess H, Kleeff J (April 2010). Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLOS Medicine. 7 (4): e1000267. doi:10.1371/journal.pmed.1000267. PMC 2857873. PMID 20422030.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Tsvetkova EV, Asmis TR (August 2014). Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarker-directed therapy here?. Current Oncology. 21 (4): e650-7. doi:10.3747/co.21.2006. PMC 4117630. PMID 25089113.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, et al. (August 2014). Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World Journal of Gastroenterology. 20 (31): 10790–801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR (July 2016). Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. The Cochrane Database of Systematic Reviews. 7: CD009323. doi:10.1002/14651858.CD009323.pub3. PMC 6458011. PMID 27383694.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. (2012). ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Rossi RE, Massironi S, Conte D, Peracchi M (January 2014). Therapy for metastatic pancreatic neuroendocrine tumors. Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01. PMC 4200651. PMID 25332984.
Buanes TA (August 2014). Pancreatic cancer-improved care achievable. World Journal of Gastroenterology. 20 (30): 10405–18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA (March 2011). Arcidiacono PG (рэд.). Celiac plexus block for pancreatic cancer pain in adults. The Cochrane Database of Systematic Reviews (3): CD007519. doi:10.1002/14651858.CD007519.pub2. PMC 6464722. PMID 21412903.
Are C, Dhir M, Ravipati L (June 2011). History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB. 13 (6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (July 2006). One thousand consecutive pancreaticoduodenectomies. Annals of Surgery. 244 (1): 10–5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. (September 2012). Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Zhang C, Yang G, Ling Y, Chen G, Zhou T (December 2014). The early diagnosis of pancreatic cancer and diabetes: what's the relationship?. Journal of Gastrointestinal Oncology. 5 (6): 481–8. doi:10.3978/j.issn.2078-6891.2014.055. PMC 4226830. PMID 25436129.
Bruenderman EH, Martin RC (March 2015). High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. The Journal of Surgical Research. 194 (1): 212–9. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Tang SC, Chen YC (Жнівень 2014). Novel therapeutic targets for pancreatic cancer. World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Rossi ML, Rehman AA, Gondi CS (August 2014). Therapeutic options for the management of pancreatic cancer. World Journal of Gastroenterology. 20 (32): 11142–59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Ady JW, Heffner J, Klein E, Fong Y (2014). Oncolytic viral therapy for pancreatic cancer: current research and future directions. Oncolytic Virotherapy. 3: 35–46. doi:10.2147/OV.S53858. PMC 4918362. PMID 27512661.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)
Ren B, Cui M, Yang G, Wang H, Feng M, You L, Zhao Y (July 2018). Tumor microenvironment participates in metastasis of pancreatic cancer. Molecular Cancer. 17 (1): 108. doi:10.1186/s12943-018-0858-1. PMC 6065152. PMID 30060755.{{cite journal}}: Папярэджанні CS1: непазначаны свабодны DOI (спасылка)

nlm.nih.gov

The Medical Subject Headings indexing system refers to «islet cell carcinoma», which is subdivided into gastrinoma, glucagonoma, somatostatinoma and VIPoma. See: 2014 MeSH tree at «Pancreatic Neoplasms [C04.588.322.475]» Архівавана 19 сакавіка 2016 года. 16 October 2014

obolibrary.org (Global: 2,299^th place; Belarusian: 126^th place)

purl.obolibrary.org

Disease Ontology — 2016. Праверана 15 мая 2019.
<a href="https://wikidata.org/wiki/Track:Q4117183"></a><a href="https://wikidata.org/wiki/Track:Q5282129"></a>

oxfordjournals.org (Global: 1,389^th place; Belarusian: 1,616^th place)

annonc.oxfordjournals.org

Oberg, K.; Knigge, U.; Kwekkeboom, D.; Perren, A.; ESMO Guidelines Working, Group. (20 September 2012). Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23 (suppl 7): vii124–vii130. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (October 2012). Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23 Suppl 7: vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.
Kleger A, Perkhofer L, Seufferlein T (July 2014). Smarter drugs emerging in pancreatic cancer therapy. Annals of Oncology. 25 (7): 1260–1270. doi:10.1093/annonc/mdu013. PMID 24631947.

pancreaticcancer.net.au (Global: low place; Belarusian: low place)

Australian Pancreatic Genome Initiative (нявызн.). Garvan Institute. Архівавана з першакрыніцы 26 July 2014. Праверана 17 July 2014.

pathologyoutlines.com (Global: low place; Belarusian: low place)

Diana Agostini-Vulaj. Pancreas - Exocrine tumors / carcinomas - Intraductal papillary mucinous neoplasm (IPMN) (нявызн.). Pathology Outlines. Topic Completed: 1 July 2018. Revised: 9 March 2020

pcrf.org.uk (Global: low place; Belarusian: low place)

Cancer facts and figures – Why we exist – Pancreatic Cancer Research Fund (нявызн.). www.pcrf.org.uk. Праверана 5 April 2019.

pravo.by (Global: 6,066^th place; Belarusian: 10^th place)

Министерство здравоохранения Республики Беларусь. Клинический протокол «Алгоритмы диагностики и лечения злокачественных новообразований» (руск.) (PDF) 151-60 (6 ліпеня 2018). Праверана 31.01.2021.
Министерство здравоохранения Республики Беларусь. Клинический протокол «Алгоритмы диагностики и лечения злокачественных новообразований» (нявызн.) (PDF) 151 (6 ліпеня 2018). Праверана 30 студзеня 2021.

proteinatlas.org (Global: low place; Belarusian: low place)

The human pathology proteome in pancreatic cancer – The Human Protein Atlas (нявызн.)(недаступная спасылка). www.proteinatlas.org. Архівавана з першакрыніцы 3 ліпеня 2020. Праверана 28 September 2017.

semanticscholar.org (Global: 11^th place; Belarusian: 3,063^rd place)

api.semanticscholar.org

Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Borazanci E, Von Hoff DD (September 2014). Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer. Expert Review of Gastroenterology & Hepatology. 8 (7): 739–47. doi:10.1586/17474124.2014.925799. PMID 24882381. S2CID 31633898.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, et al. (2012). ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 95 (2): 120–34. doi:10.1159/000335587. PMID 22261872. S2CID 6985904.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, et al. (2012). ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 95 (2): 157–76. doi:10.1159/000335597. PMID 22262022. S2CID 2097604.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (June 2015). Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors. Cancer Chemotherapy and Pharmacology. 75 (6): 1099–114. doi:10.1007/s00280-014-2642-2. PMID 25480314. S2CID 39434924.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, et al. (August 2015). Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group. Annals of Surgical Oncology. 22 (8): 2685–99. doi:10.1245/s10434-014-4145-0. PMID 25366583. S2CID 8129133.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). Cancer statistics, 2007. Ca. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (September 2015). Pancreatic cancer genomics: where can the science take us?. Clinical Genetics. 88 (3): 213–9. doi:10.1111/cge.12536. PMID 25388820. S2CID 26414866.

semanticscholar.org

Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). Cancer statistics, 2007. Ca. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.

uspreventiveservicestaskforce.org (Global: low place; Belarusian: low place)

Draft Recommendation Statement: Pancreatic Cancer: Screening – US Preventive Services Task Force (нявызн.). www.uspreventiveservicestaskforce.org. Праверана 11 February 2019.

web.archive.org (Global: 1^st place; Belarusian: 2^nd place)

What is Cancer? Defining Cancer (нявызн.). National Cancer Institute, National Institutes of Health (7 сакавіка 2014). Архівавана з першакрыніцы 25 June 2014. Праверана 5 December 2014.
Pancreatic Cancer Treatment (PDQ®) Patient Version (нявызн.). National Cancer Institute. National Institutes of Health (17 красавіка 2014). Архівавана з першакрыніцы 5 July 2014. Праверана 8 June 2014.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (Жнівень 2011). Pancreatic cancer (PDF). Lancet. 378 (9791): 607–620. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Архівавана з арыгінала (PDF) 12 студзеня 2015. Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.
Can pancreatic cancer be prevented? (нявызн.). American Cancer Society (11 чэрвеня 2014). Архівавана з першакрыніцы 13 November 2014. Праверана 13 November 2014.
Chapter 15; Pancreas (PDF). Manual for Staging of Cancer (2nd ed.). American Joint Committee on Cancer. pp. 95–98. Архівавана (PDF) з арыгінала 29 Лістапад 2014. See p. 95 for citation regarding «… lesser degree of involvement of bones and brain and other anatomical sites.»
Pancreatic Cancer Treatment (PDQ®) Health Professional Version (нявызн.). National Cancer Institute. National Institutes of Health (21 лютага 2014). Архівавана з першакрыніцы 22 October 2014. Праверана 24 November 2014. «The highest cure rate occurs if the tumor is truly localized to the pancreas; however, this stage of disease accounts for less than 20 % of cases. In cases with localized disease and small cancers (<2 cm) with no lymph node metastases and no extension beyond the capsule of the pancreas, complete surgical resection is still associated with a low actuarial five-year survival rate of 18 % to 24 %.»
Harris, RE (2013). Epidemiology of pancreatic cancer. Epidemiology of Chronic Disease. Jones & Bartlett. pp. 181–190. ISBN 978-0-7637-8047-0. Архівавана з арыгінала 24 чэрвеня 2016.
Handbook of Pancreatic Cancer. New York: Springer. 2009. p. 288. ISBN 978-0-387-77497-8. Архівавана з арыгінала 10 September 2017. Праверана 12 June 2016.
Types of Pancreas Tumors (нявызн.). The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine (16 кастрычніка 2012). Архівавана з першакрыніцы 8 October 2014. Праверана 18 November 2014.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system WHO classification of tumours of the digestive system – NLM Catalog – NCBI (нявызн.). Архівавана з першакрыніцы 9 September 2017. Праверана 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called «pancreatic endocrine tumors». See: Klimstra, David S.; Modlin, Irvin R.; Coppola, Domenico; Lloyd, Ricardo V.; Suster, Saul (August 2010). The Pathologic Classification of Neuroendocrine Tumors. Pancreas. 39 (6): 707–712. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470.
The Medical Subject Headings indexing system refers to «islet cell carcinoma», which is subdivided into gastrinoma, glucagonoma, somatostatinoma and VIPoma. See: 2014 MeSH tree at «Pancreatic Neoplasms [C04.588.322.475]» Архівавана 19 сакавіка 2016 года. 16 October 2014
Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas (нявызн.). The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine (16 кастрычніка 2012). Архівавана з першакрыніцы 5 January 2015. Праверана 5 January 2015.
Causes of pancreatic cancer (нявызн.). NHS Choices. National Health Service, England (7 кастрычніка 2014). Архівавана з першакрыніцы 6 November 2014. Праверана 5 December 2014.
Cancer Facts and Figures 2014 (нявызн.). American Cancer Society. Архівавана з першакрыніцы 18 December 2014. Праверана 5 January 2015., p. 19, «Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk.»
The human pathology proteome in pancreatic cancer – The Human Protein Atlas (нявызн.)(недаступная спасылка). www.proteinatlas.org. Архівавана з першакрыніцы 3 ліпеня 2020. Праверана 28 September 2017.
Staging of pancreatic cancer (нявызн.)(недаступная спасылка). American Cancer Society (11 чэрвеня 2014). Архівавана з першакрыніцы 10 жніўня 2020. Праверана 29 September 2014.
Zyromski, Nicholas J.; Nakeeb, Attila; Lillemoe, Keith D. (2010). Silberman, Howard; Silberman, Allan W. (рэд-ры). Principles and practice of surgical oncology : multidisciplinary approach to difficult problems (online ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. Chapter 35. ISBN 978-0-7817-6546-6. Архівавана з арыгінала 6 February 2015. Праверана 3 November 2014.{{cite book}}: Папярэджанні CS1: бот: невядомы статус арыгінальнага URL (спасылка) Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 6 лютага 2015. Праверана 7 жніўня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 6 лютага 2015. Праверана 7 жніўня 2020.
Neuroendocrine tumors, NCCN Guidelines Version 1.2015 (нявызн.)(недаступная спасылка). National Comprehensive Cancer Network, Inc. NCCN) (11 лістапада 2014). Архівавана з першакрыніцы 24 красавіка 2021. Праверана 25 December 2014.
National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality Archived copy (нявызн.). Архівавана з першакрыніцы 4 January 2015. Праверана 29 December 2014.
Diet and activity factors that affect risks for certain cancers: Pancreatic cancer section (нявызн.). American Cancer Society (20 жніўня 2012). Архівавана з першакрыніцы 4 November 2014. Праверана 4 November 2014.
Pancreatic adenocarcinoma. NCCN Guidelines Version 1.2015 (нявызн.)(недаступная спасылка). NCCN Guidelines. National Comprehensive Cancer Network, Inc. (4 снежня 2014). Архівавана з першакрыніцы 8 лютага 2007. Праверана 26 December 2014.
Cancer Drug Information: FDA Approval for Erlotinib Hydrochloride (нявызн.)(недаступная спасылка). National Cancer Institute. National Institutes of Health (3 ліпеня 2013). Архівавана з першакрыніцы 29 лістапада 2014. Праверана 10 студзеня 2021.
Palliative or Supportive Care (нявызн.). American Cancer Society (16 кастрычніка 2014). Архівавана з першакрыніцы 21 August 2014. Праверана 20 August 2014.
If treatment for pancreatic cancer stops working (нявызн.). American Cancer Society (11 чэрвеня 2014). Архівавана з першакрыніцы 22 October 2014. Праверана 20 August 2014.
Cancer Facts and Figures 2014 (нявызн.). American Cancer Society. Архівавана з першакрыніцы 18 December 2014. Праверана 5 January 2015., Table, p. 18, rates adjusted for normal life expectancy
Pancreatic cancer research (нявызн.). Cancer Research UK. Архівавана з першакрыніцы 18 February 2014. Праверана 17 July 2014.
Australian Pancreatic Genome Initiative (нявызн.). Garvan Institute. Архівавана з першакрыніцы 26 July 2014. Праверана 17 July 2014.
About EUROPAC (нявызн.)(недаступная спасылка). European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC). University of Liverpool. Архівавана з першакрыніцы 26 July 2014. Праверана 17 July 2014.

wikidata.org (Global: 43^rd place; Belarusian: 1^st place)

Disease Ontology — 2016. Праверана 15 мая 2019.
<a href="https://wikidata.org/wiki/Track:Q4117183"></a><a href="https://wikidata.org/wiki/Track:Q5282129"></a>

worldcat.org (Global: 5^th place; Belarusian: 13^th place)

Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjöstedt, Evelina; Fagerberg, Linn; Bidkhori, Gholamreza; Benfeitas, Rui; Arif, Muhammad; Liu, Zhengtao (18 August 2017). A pathology atlas of the human cancer transcriptome. Science(англ.). 357 (6352): eaan2507. doi:10.1126/science.aan2507. ISSN 0036-8075. PMID 28818916.
Skafida, Evangelia; Grammatoglou, Xanthippi; Glava, Chryssoula; Zissis, Dimitrios; Paschalidis, Nikolaos; Katsamagkou, Eleftheria; Firfiris, Nikolaos; Vasilakaki, Thivi (2010). Adenosquamous carcinoma of the pancreas: a case report. Cases Journal. 3 (1). doi:10.1186/1757-1626-3-41. ISSN 1757-1626.
Adsay, Volkan; Mino-Kenudson, Mari; Furukawa, Toru; Basturk, Olca; Zamboni, Giuseppe; Marchegiani, Giovanni; Bassi, Claudio; Salvia, Roberto; Malleo, Giuseppe; Paiella, Salvatore; Wolfgang, Christopher L.; Matthaei, Hanno; Offerhaus, G. Johan; Adham, Mustapha; Bruno, Marco J.; Reid, Michelle D.; Krasinskas, Alyssa; Klöppel, Günter; Ohike, Nobuyuki; Tajiri, Takuma; Jang, Kee-Taek; Roa, Juan Carlos; Allen, Peter; Castillo, Carlos Fernández-del; Jang, Jin-Young; Klimstra, David S.; Hruban, Ralph H. (2016). Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract. Annals of Surgery. 263 (1): 162–177. doi:10.1097/SLA.0000000000001173. ISSN 0003-4932. PMC 4568174. PMID 25775066.

zju.edu.cn (Global: low place; Belarusian: low place)

m-learning.zju.edu.cn

Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (Жнівень 2011). Pancreatic cancer (PDF). Lancet. 378 (9791): 607–620. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Архівавана з арыгінала (PDF) 12 студзеня 2015. Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.Архіўная копія (нявызн.)(недаступная спасылка). Архівавана з першакрыніцы 12 студзеня 2015. Праверана 11 ліпеня 2020.

Рак падстраўнікавай залозы (Belarusian Wikipedia)

archive.org (Global: 6th place; Belarusian: 44th place)

books.google.com (Global: 3rd place; Belarusian: 25th place)

cancer.gov (Global: 1,684th place; Belarusian: 4,262nd place)

cancer.gov

seer.cancer.gov

cancer.org (Global: 3,680th place; Belarusian: low place)

cancerresearchuk.org (Global: 8,489th place; Belarusian: low place)

cancerstaging.org (Global: low place; Belarusian: low place)

doi.org (Global: 2nd place; Belarusian: 22nd place)

europac-org.eu (Global: low place; Belarusian: low place)

handle.net (Global: 102nd place; Belarusian: 1,042nd place)

hdl.handle.net

harvard.edu (Global: 18th place; Belarusian: 75th place)

ui.adsabs.harvard.edu

iarc.fr (Global: 4,025th place; Belarusian: 7,594th place)

publications.iarc.fr

jhu.edu (Global: 699th place; Belarusian: 463rd place)

pathology.jhu.edu

lwwoncology.com (Global: low place; Belarusian: low place)

nccn.org (Global: low place; Belarusian: low place)

nhs.uk (Global: 1,989th place; Belarusian: 2,156th place)

nih.gov (Global: 4th place; Belarusian: 66th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nlm.nih.gov

obolibrary.org (Global: 2,299th place; Belarusian: 126th place)

purl.obolibrary.org

oxfordjournals.org (Global: 1,389th place; Belarusian: 1,616th place)

annonc.oxfordjournals.org

pancreaticcancer.net.au (Global: low place; Belarusian: low place)

pathologyoutlines.com (Global: low place; Belarusian: low place)

pcrf.org.uk (Global: low place; Belarusian: low place)

pravo.by (Global: 6,066th place; Belarusian: 10th place)

proteinatlas.org (Global: low place; Belarusian: low place)

semanticscholar.org (Global: 11th place; Belarusian: 3,063rd place)

api.semanticscholar.org

semanticscholar.org

uspreventiveservicestaskforce.org (Global: low place; Belarusian: low place)

web.archive.org (Global: 1st place; Belarusian: 2nd place)

wikidata.org (Global: 43rd place; Belarusian: 1st place)

worldcat.org (Global: 5th place; Belarusian: 13th place)

zju.edu.cn (Global: low place; Belarusian: low place)

m-learning.zju.edu.cn

archive.org (Global: 6^th place; Belarusian: 44^th place)

books.google.com (Global: 3^rd place; Belarusian: 25^th place)

cancer.gov (Global: 1,684^th place; Belarusian: 4,262^nd place)

cancer.org (Global: 3,680^th place; Belarusian: low place)

cancerresearchuk.org (Global: 8,489^th place; Belarusian: low place)

doi.org (Global: 2^nd place; Belarusian: 22^nd place)

handle.net (Global: 102^nd place; Belarusian: 1,042^nd place)

harvard.edu (Global: 18^th place; Belarusian: 75^th place)

iarc.fr (Global: 4,025^th place; Belarusian: 7,594^th place)

jhu.edu (Global: 699^th place; Belarusian: 463^rd place)

nhs.uk (Global: 1,989^th place; Belarusian: 2,156^th place)

nih.gov (Global: 4^th place; Belarusian: 66^th place)

obolibrary.org (Global: 2,299^th place; Belarusian: 126^th place)

oxfordjournals.org (Global: 1,389^th place; Belarusian: 1,616^th place)

pravo.by (Global: 6,066^th place; Belarusian: 10^th place)

semanticscholar.org (Global: 11^th place; Belarusian: 3,063^rd place)

web.archive.org (Global: 1^st place; Belarusian: 2^nd place)

wikidata.org (Global: 43^rd place; Belarusian: 1^st place)

worldcat.org (Global: 5^th place; Belarusian: 13^th place)